Literature DB >> 6249

Experience with beta-adrenoreceptor blockers in hypertension.

H Waal-Manning.   

Abstract

At the Dunedin Hypertension Clinic beta-blockers are the drugs of choice for most hypertensive patients, usually in combination with diuretics (especially in older subjects) and often with other drugs in the more severe cases. All beta-blockers have an antihypertensive effect, regardless of other characteristics (e.g. cardio-selectivity, instrinsic sympathomimetic effect, or membrane activity). d-Propranolol has no significant effect on blood pressure. Beta-blockers do not prevent stress-induced (mental arithmetic) rises in blood pressure in hypertensive subjects through the level of blood pressure reached during stress tends to be lower because the base line is lower. Twice-daily dosage of beta-blockers is usually satisfactory.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 6249     DOI: 10.2165/00003495-197600111-00034

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  4 in total

1.  Letter: Paradoxical effect of pindolol.

Authors:  H J Waal-Manning; F O Simpson
Journal:  Br Med J       Date:  1975-07-19

2.  Pindolol in hypertension: twice-daily versus thrice-daily dosage.

Authors:  H J Waal-Manning; A J Wood
Journal:  Med J Aust       Date:  1975-08-16       Impact factor: 7.738

3.  Pindolol: a comparison with other antihypertensive drugs and a double-blind placebo trial.

Authors:  H J Waal-Manning; F O Simpson
Journal:  N Z Med J       Date:  1974-08-28

4.  Propranolol-induced depression.

Authors:  H J Waal
Journal:  Br Med J       Date:  1967-04-01
  4 in total
  2 in total

Review 1.  Metoprolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-11       Impact factor: 9.546

2.  Low-dose propranolol for the protection of the left ventricle from ischaemic damage.

Authors:  A H Brown; B L Krause; G M Morritt
Journal:  Thorax       Date:  1981-11       Impact factor: 9.139

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.